JP Stock MarketDetailed Quotes

4521 Kaken Pharmaceutical

Watchlist
  • 4005.0
  • -50.0-1.23%
20min DelayTrading May 8 13:38 JST
183.99BMarket Cap18.83P/E (Static)

Kaken Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kaken Pharmaceutical FY2025 Estimates Date

Currency：JPYMay 12, 2025

Estimate YoY
Revenue
90.55B
+25.69%
EPS
390.80
+83.76%
Analyst Rating
Buy

Nov 18, 2024

Kaken Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Feb 6, 20252025/Q324.618B / ----
Aug 7, 20242025/Q118.254B / ----
Feb 6, 20242024/Q318.514B / ----
Aug 4, 20232024/Q118.150B / ----
Feb 3, 20232023/Q318.754B / ----
DatePeriodRevenue/EstimateEarnings Call
Feb 6, 20252025/Q324.618B / ----
Aug 7, 20242025/Q118.254B / ----
Feb 6, 20242024/Q318.514B / ----
Aug 4, 20232024/Q118.150B / ----
Feb 3, 20232023/Q318.754B / ----

Unlock Free Earnings Estimates

Kaken Pharmaceutical Earnings Reports

  • Kaken Pharmaceutical: Notice regarding revisions to earnings forecasts

    Apr 8 02:30 ET

  • Kaken Pharmaceutical: Summary of Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2025 [Japanese GAAP] (Consolidated)

    Feb 6 01:30 ET

  • Kaken Pharmaceutical: Confirmation letter

    Nov 12, 2024 23:25 ET

  • Kaken Pharmaceutical: Semi-annual report - 105th period (2024/04/01 - 2025/03/31)

    Nov 12, 2024 23:24 ET

    • Read more

    Market Insights

    Market Hot Picks Market Hot Picks
    No. Symbol Price
    Nippon Telegraph & Telephone
    9432
    149.6
    Metaplanet
    3350
    498
    NTT Data Group
    9613
    2991.5
    4
    Mitsubishi Heavy Industries
    7011
    2906.5
    5
    Mitsubishi
    8058
    2709.0
    Log In for the Full List
    Unlock Now